Ubs Asset Management Americas Inc Alkermes Plc. Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 195,442 shares of ALKS stock, worth $4.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
195,442
Previous 189,906
2.92%
Holding current value
$4.74 Million
Previous $5.27 Million
0.44%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding ALKS
# of Institutions
357Shares Held
180MCall Options Held
522KPut Options Held
463K-
Black Rock Inc. New York, NY29.2MShares$707 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.2MShares$489 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$361 Million0.07% of portfolio
-
State Street Corp Boston, MA9MShares$218 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$202 Million0.03% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $3.98B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...